nodes	percent_of_prediction	percent_of_DWPC	metapath
Vitamin E—PPP2CB—Serotonin Transporter Activity—SLC6A4—conduct disorder	0.0341	0.0439	CbGpPWpGaD
Vitamin E—TTPA—brain—conduct disorder	0.0334	0.149	CbGeAlD
Vitamin E—PPP2CB—Serotonin Transporter Activity—MAOA—conduct disorder	0.0256	0.033	CbGpPWpGaD
Vitamin E—HMOX1—Oxidative Stress—MAOA—conduct disorder	0.0245	0.0315	CbGpPWpGaD
Vitamin E—SOD1—Dopamine metabolism—COMT—conduct disorder	0.0238	0.0306	CbGpPWpGaD
Vitamin E—SOD1—Dopamine metabolism—MAOA—conduct disorder	0.0236	0.0304	CbGpPWpGaD
Vitamin E—PRKCB—brain—conduct disorder	0.0229	0.102	CbGeAlD
Vitamin E—SEC14L2—brain—conduct disorder	0.0229	0.102	CbGeAlD
Vitamin E—PPP2CB—Dopamine metabolism—COMT—conduct disorder	0.0226	0.0291	CbGpPWpGaD
Vitamin E—PPP2CB—Dopamine metabolism—MAOA—conduct disorder	0.0224	0.0289	CbGpPWpGaD
Vitamin E—PPP2CA—Dopamine metabolism—COMT—conduct disorder	0.0212	0.0272	CbGpPWpGaD
Vitamin E—PPP2CA—Dopamine metabolism—MAOA—conduct disorder	0.021	0.027	CbGpPWpGaD
Vitamin E—NQO1—Dopamine metabolism—COMT—conduct disorder	0.0202	0.0261	CbGpPWpGaD
Vitamin E—NQO1—Dopamine metabolism—MAOA—conduct disorder	0.0201	0.0259	CbGpPWpGaD
Vitamin E—DGKA—brain—conduct disorder	0.0189	0.0847	CbGeAlD
Vitamin E—PPP2CA—brain—conduct disorder	0.0186	0.0835	CbGeAlD
Vitamin E—GCLC—Oxidative Stress—MAOA—conduct disorder	0.0169	0.0217	CbGpPWpGaD
Vitamin E—PPP2CB—brain—conduct disorder	0.0159	0.071	CbGeAlD
Vitamin E—NQO1—Estrogen metabolism—COMT—conduct disorder	0.0156	0.0201	CbGpPWpGaD
Vitamin E—PRKCA—FSH signaling pathway—CGA—conduct disorder	0.0147	0.019	CbGpPWpGaD
Vitamin E—PPP2CB—Monoamine Transport—SLC6A4—conduct disorder	0.0145	0.0187	CbGpPWpGaD
Vitamin E—HMOX1—brain—conduct disorder	0.0138	0.0617	CbGeAlD
Vitamin E—SOD1—Oxidative Stress—MAOA—conduct disorder	0.0121	0.0156	CbGpPWpGaD
Vitamin E—GCLC—brain—conduct disorder	0.0119	0.0534	CbGeAlD
Vitamin E—GSTM3—brain—conduct disorder	0.0106	0.0477	CbGeAlD
Vitamin E—NQO1—Oxidative Stress—MAOA—conduct disorder	0.0103	0.0133	CbGpPWpGaD
Vitamin E—GSTO1—brain—conduct disorder	0.0099	0.0444	CbGeAlD
Vitamin E—GSTM3—Phase II conjugation—COMT—conduct disorder	0.00947	0.0122	CbGpPWpGaD
Vitamin E—HMOX1—NRF2 pathway—SLC6A4—conduct disorder	0.00918	0.0118	CbGpPWpGaD
Vitamin E—SOD1—brain—conduct disorder	0.00911	0.0408	CbGeAlD
Vitamin E—HMOX1—Validated transcriptional targets of AP1 family members Fra1 and Fra2—EP300—conduct disorder	0.00894	0.0115	CbGpPWpGaD
Vitamin E—PRKCA—brain—conduct disorder	0.00882	0.0395	CbGeAlD
Vitamin E—GCLC—Amino acid and derivative metabolism—CGA—conduct disorder	0.00866	0.0111	CbGpPWpGaD
Vitamin E—GSTO1—Phase II conjugation—COMT—conduct disorder	0.00856	0.011	CbGpPWpGaD
Vitamin E—GSTA2—brain—conduct disorder	0.00845	0.0379	CbGeAlD
Vitamin E—GSTM3—NRF2 pathway—SLC6A4—conduct disorder	0.00833	0.0107	CbGpPWpGaD
Vitamin E—PRKCB—VEGFA-VEGFR2 Pathway—WASF1—conduct disorder	0.00773	0.00995	CbGpPWpGaD
Vitamin E—PRKCB—Signaling by VEGF—WASF1—conduct disorder	0.0073	0.0094	CbGpPWpGaD
Vitamin E—PRKCB—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA2—conduct disorder	0.0073	0.00939	CbGpPWpGaD
Vitamin E—GCLC—Phase II conjugation—COMT—conduct disorder	0.00718	0.00924	CbGpPWpGaD
Vitamin E—ALOX5—brain—conduct disorder	0.0066	0.0295	CbGeAlD
Vitamin E—GCLC—NRF2 pathway—SLC6A4—conduct disorder	0.00631	0.00813	CbGpPWpGaD
Vitamin E—PRKCA—Melatonin metabolism and effects—MAOA—conduct disorder	0.00623	0.00803	CbGpPWpGaD
Vitamin E—NQO1—brain—conduct disorder	0.00607	0.0272	CbGeAlD
Vitamin E—HMOX1—HIF-1-alpha transcription factor network—EP300—conduct disorder	0.00563	0.00725	CbGpPWpGaD
Vitamin E—GSTM3—Biological oxidations—COMT—conduct disorder	0.00554	0.00713	CbGpPWpGaD
Vitamin E—GSTM3—Biological oxidations—MAOA—conduct disorder	0.0055	0.00708	CbGpPWpGaD
Vitamin E—PRKCB—Transmission across Chemical Synapses—GABRA2—conduct disorder	0.00549	0.00706	CbGpPWpGaD
Vitamin E—GSTM3—Metapathway biotransformation—COMT—conduct disorder	0.00546	0.00703	CbGpPWpGaD
Vitamin E—GSTA2—Phase II conjugation—COMT—conduct disorder	0.00544	0.007	CbGpPWpGaD
Vitamin E—GSTP1—brain—conduct disorder	0.00543	0.0243	CbGeAlD
Vitamin E—NQO1—Amino acid and derivative metabolism—CGA—conduct disorder	0.00529	0.00681	CbGpPWpGaD
Vitamin E—GCLC—Aryl Hydrocarbon Receptor—EP300—conduct disorder	0.00517	0.00666	CbGpPWpGaD
Vitamin E—GSTO1—Biological oxidations—COMT—conduct disorder	0.00501	0.00645	CbGpPWpGaD
Vitamin E—DGKA—G alpha (q) signalling events—HTR2A—conduct disorder	0.005	0.00644	CbGpPWpGaD
Vitamin E—GSTO1—Biological oxidations—MAOA—conduct disorder	0.00497	0.0064	CbGpPWpGaD
Vitamin E—GSTO1—Metapathway biotransformation—COMT—conduct disorder	0.00494	0.00636	CbGpPWpGaD
Vitamin E—GSTA2—NRF2 pathway—SLC6A4—conduct disorder	0.00479	0.00616	CbGpPWpGaD
Vitamin E—HMOX1—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00463	0.00596	CbGpPWpGaD
Vitamin E—GSTP1—Phase II conjugation—COMT—conduct disorder	0.0045	0.00579	CbGpPWpGaD
Vitamin E—DGKA—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—conduct disorder	0.00448	0.00576	CbGpPWpGaD
Vitamin E—PRKCB—Neuronal System—GABRA2—conduct disorder	0.0042	0.00541	CbGpPWpGaD
Vitamin E—GCLC—Biological oxidations—COMT—conduct disorder	0.0042	0.0054	CbGpPWpGaD
Vitamin E—GCLC—Biological oxidations—MAOA—conduct disorder	0.00417	0.00537	CbGpPWpGaD
Vitamin E—GSTP1—NRF2 pathway—SLC6A4—conduct disorder	0.00396	0.0051	CbGpPWpGaD
Vitamin E—PRKCA—VEGFA-VEGFR2 Pathway—WASF1—conduct disorder	0.00392	0.00505	CbGpPWpGaD
Vitamin E—GSTA2—Aryl Hydrocarbon Receptor Pathway—EP300—conduct disorder	0.00392	0.00504	CbGpPWpGaD
Vitamin E—DGKA—GPCR downstream signaling—CGA—conduct disorder	0.0039	0.00502	CbGpPWpGaD
Vitamin E—NQO1—NRF2 pathway—SLC6A4—conduct disorder	0.00386	0.00497	CbGpPWpGaD
Vitamin E—SOD1—FOXA1 transcription factor network—EP300—conduct disorder	0.00385	0.00496	CbGpPWpGaD
Vitamin E—PRKCA—Signaling by VEGF—WASF1—conduct disorder	0.0037	0.00477	CbGpPWpGaD
Vitamin E—PRKCA—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA2—conduct disorder	0.0037	0.00477	CbGpPWpGaD
Vitamin E—DGKA—Signaling by GPCR—CGA—conduct disorder	0.00354	0.00456	CbGpPWpGaD
Vitamin E—PRKCB—Role of Calcineurin-dependent NFAT signaling in lymphocytes—EP300—conduct disorder	0.00323	0.00415	CbGpPWpGaD
Vitamin E—GSTA2—Biological oxidations—COMT—conduct disorder	0.00318	0.0041	CbGpPWpGaD
Vitamin E—GSTA2—Biological oxidations—MAOA—conduct disorder	0.00316	0.00407	CbGpPWpGaD
Vitamin E—NQO1—Aryl Hydrocarbon Receptor Pathway—EP300—conduct disorder	0.00316	0.00407	CbGpPWpGaD
Vitamin E—NQO1—Aryl Hydrocarbon Receptor—EP300—conduct disorder	0.00316	0.00407	CbGpPWpGaD
Vitamin E—PPP2CB—Innate Immune System—MB21D1—conduct disorder	0.00312	0.00402	CbGpPWpGaD
Vitamin E—PRKCB—Kit receptor signaling pathway—EP300—conduct disorder	0.00301	0.00387	CbGpPWpGaD
Vitamin E—PPP2CA—Innate Immune System—MB21D1—conduct disorder	0.00292	0.00376	CbGpPWpGaD
Vitamin E—SOD1—Validated nuclear estrogen receptor alpha network—EP300—conduct disorder	0.00285	0.00367	CbGpPWpGaD
Vitamin E—PRKCA—Transmission across Chemical Synapses—GABRA2—conduct disorder	0.00278	0.00358	CbGpPWpGaD
Vitamin E—NQO1—Validated transcriptional targets of TAp63 isoforms—EP300—conduct disorder	0.00278	0.00358	CbGpPWpGaD
Vitamin E—PPP2CA—p53 pathway—EP300—conduct disorder	0.0027	0.00348	CbGpPWpGaD
Vitamin E—PRKCB—Transmission across Chemical Synapses—COMT—conduct disorder	0.00264	0.0034	CbGpPWpGaD
Vitamin E—GSTP1—Biological oxidations—COMT—conduct disorder	0.00263	0.00339	CbGpPWpGaD
Vitamin E—PRKCB—Transmission across Chemical Synapses—MAOA—conduct disorder	0.00262	0.00338	CbGpPWpGaD
Vitamin E—PRKCA—Retinoic acid receptors-mediated signaling—EP300—conduct disorder	0.00262	0.00337	CbGpPWpGaD
Vitamin E—GSTP1—Biological oxidations—MAOA—conduct disorder	0.00261	0.00336	CbGpPWpGaD
Vitamin E—GSTP1—Metapathway biotransformation—COMT—conduct disorder	0.0026	0.00334	CbGpPWpGaD
Vitamin E—PPP2CA—Regulation of retinoblastoma protein—EP300—conduct disorder	0.00247	0.00318	CbGpPWpGaD
Vitamin E—HMOX1—Metabolism—CGA—conduct disorder	0.00231	0.00298	CbGpPWpGaD
Vitamin E—PRKCB—Signaling Pathways in Glioblastoma—EP300—conduct disorder	0.00231	0.00297	CbGpPWpGaD
Vitamin E—PPP2CB—Innate Immune System—POLR3A—conduct disorder	0.00229	0.00295	CbGpPWpGaD
Vitamin E—DGKA—GPCR downstream signaling—DRD4—conduct disorder	0.00219	0.00281	CbGpPWpGaD
Vitamin E—PPP2CA—Innate Immune System—POLR3A—conduct disorder	0.00215	0.00276	CbGpPWpGaD
Vitamin E—PRKCA—Neuronal System—GABRA2—conduct disorder	0.00213	0.00275	CbGpPWpGaD
Vitamin E—ALOX5—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00211	0.00272	CbGpPWpGaD
Vitamin E—GSTM3—Metabolism—CGA—conduct disorder	0.0021	0.0027	CbGpPWpGaD
Vitamin E—DGKA—Signaling Pathways—CGA—conduct disorder	0.00209	0.0027	CbGpPWpGaD
Vitamin E—PRKCB—Neuronal System—COMT—conduct disorder	0.00202	0.0026	CbGpPWpGaD
Vitamin E—PRKCB—Neuronal System—MAOA—conduct disorder	0.00201	0.00259	CbGpPWpGaD
Vitamin E—DGKA—Signaling by GPCR—DRD4—conduct disorder	0.00198	0.00256	CbGpPWpGaD
Vitamin E—PRKCB—Wnt Signaling Pathway and Pluripotency—EP300—conduct disorder	0.00194	0.0025	CbGpPWpGaD
Vitamin E—PPP2CB—Innate Immune System—WASF1—conduct disorder	0.00193	0.00248	CbGpPWpGaD
Vitamin E—GSTO1—Metabolism—CGA—conduct disorder	0.0019	0.00244	CbGpPWpGaD
Vitamin E—PRKCB—Immune System—MB21D1—conduct disorder	0.00189	0.00244	CbGpPWpGaD
Vitamin E—PPP2CB—Wnt Signaling Pathway and Pluripotency—EP300—conduct disorder	0.00186	0.0024	CbGpPWpGaD
Vitamin E—PPP2CB—Immune System—MB21D1—conduct disorder	0.00182	0.00234	CbGpPWpGaD
Vitamin E—PPP2CA—Innate Immune System—WASF1—conduct disorder	0.00181	0.00233	CbGpPWpGaD
Vitamin E—PRKCB—GPCR downstream signaling—CGA—conduct disorder	0.00176	0.00226	CbGpPWpGaD
Vitamin E—PPP2CA—Wnt Signaling Pathway and Pluripotency—EP300—conduct disorder	0.00175	0.00225	CbGpPWpGaD
Vitamin E—PPP2CB—G2/M Transition—EP300—conduct disorder	0.00172	0.00221	CbGpPWpGaD
Vitamin E—PPP2CA—Immune System—MB21D1—conduct disorder	0.0017	0.00219	CbGpPWpGaD
Vitamin E—PPP2CB—Mitotic G2-G2/M phases—EP300—conduct disorder	0.00169	0.00218	CbGpPWpGaD
Vitamin E—DGKA—Signaling Pathways—WASF1—conduct disorder	0.00168	0.00216	CbGpPWpGaD
Vitamin E—PRKCA—Innate Immune System—MB21D1—conduct disorder	0.00165	0.00212	CbGpPWpGaD
Vitamin E—PRKCA—Role of Calcineurin-dependent NFAT signaling in lymphocytes—EP300—conduct disorder	0.00164	0.00211	CbGpPWpGaD
Vitamin E—PPP2CA—G2/M Transition—EP300—conduct disorder	0.00161	0.00207	CbGpPWpGaD
Vitamin E—PRKCB—Signaling by GPCR—CGA—conduct disorder	0.0016	0.00206	CbGpPWpGaD
Vitamin E—GCLC—Metabolism—CGA—conduct disorder	0.00159	0.00205	CbGpPWpGaD
Vitamin E—PPP2CA—Mitotic G2-G2/M phases—EP300—conduct disorder	0.00159	0.00204	CbGpPWpGaD
Vitamin E—PPP2CB—Signaling by GPCR—CGA—conduct disorder	0.00153	0.00198	CbGpPWpGaD
Vitamin E—PRKCA—ATF-2 transcription factor network—EP300—conduct disorder	0.00153	0.00196	CbGpPWpGaD
Vitamin E—PRKCA—Kit receptor signaling pathway—EP300—conduct disorder	0.00153	0.00196	CbGpPWpGaD
Vitamin E—NR1I2—Gene Expression—POLR3A—conduct disorder	0.0015	0.00193	CbGpPWpGaD
Vitamin E—PPP2CA—Signaling by GPCR—CGA—conduct disorder	0.00144	0.00185	CbGpPWpGaD
Vitamin E—DGKA—GPCR downstream signaling—HTR2A—conduct disorder	0.00143	0.00184	CbGpPWpGaD
Vitamin E—PRKCB—Immune System—POLR3A—conduct disorder	0.00139	0.00179	CbGpPWpGaD
Vitamin E—PRKCA—Transmission across Chemical Synapses—COMT—conduct disorder	0.00134	0.00172	CbGpPWpGaD
Vitamin E—PPP2CB—Immune System—POLR3A—conduct disorder	0.00133	0.00172	CbGpPWpGaD
Vitamin E—PRKCA—Transmission across Chemical Synapses—MAOA—conduct disorder	0.00133	0.00171	CbGpPWpGaD
Vitamin E—DGKA—Signaling by GPCR—HTR2A—conduct disorder	0.0013	0.00167	CbGpPWpGaD
Vitamin E—PPP2CA—Immune System—POLR3A—conduct disorder	0.00125	0.00161	CbGpPWpGaD
Vitamin E—PPP2CA—Gene Expression—POLR3A—conduct disorder	0.00124	0.0016	CbGpPWpGaD
Vitamin E—PRKCA—Innate Immune System—POLR3A—conduct disorder	0.00121	0.00156	CbGpPWpGaD
Vitamin E—GSTA2—Metabolism—CGA—conduct disorder	0.00121	0.00155	CbGpPWpGaD
Vitamin E—DGKA—Hemostasis—EP300—conduct disorder	0.0012	0.00154	CbGpPWpGaD
Vitamin E—DGKA—Signaling Pathways—DRD4—conduct disorder	0.00117	0.00151	CbGpPWpGaD
Vitamin E—PRKCA—Signaling Pathways in Glioblastoma—EP300—conduct disorder	0.00117	0.00151	CbGpPWpGaD
Vitamin E—PRKCB—Immune System—WASF1—conduct disorder	0.00117	0.00151	CbGpPWpGaD
Vitamin E—PPP2CB—Immune System—WASF1—conduct disorder	0.00112	0.00145	CbGpPWpGaD
Vitamin E—PPP2CB—Metabolism—CGA—conduct disorder	0.00108	0.0014	CbGpPWpGaD
Vitamin E—PPP2CA—Immune System—WASF1—conduct disorder	0.00105	0.00135	CbGpPWpGaD
Vitamin E—HMOX1—Metabolism—COMT—conduct disorder	0.00104	0.00134	CbGpPWpGaD
Vitamin E—HMOX1—Metabolism—MAOA—conduct disorder	0.00104	0.00133	CbGpPWpGaD
Vitamin E—PRKCA—Neuronal System—COMT—conduct disorder	0.00103	0.00132	CbGpPWpGaD
Vitamin E—PRKCA—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—conduct disorder	0.00102	0.00132	CbGpPWpGaD
Vitamin E—PRKCA—Neuronal System—MAOA—conduct disorder	0.00102	0.00131	CbGpPWpGaD
Vitamin E—PRKCA—Innate Immune System—WASF1—conduct disorder	0.00102	0.00131	CbGpPWpGaD
Vitamin E—PPP2CA—Metabolism—CGA—conduct disorder	0.00102	0.00131	CbGpPWpGaD
Vitamin E—PPP2CB—TCF dependent signaling in response to WNT—EP300—conduct disorder	0.00102	0.00131	CbGpPWpGaD
Vitamin E—GSTP1—Metabolism—CGA—conduct disorder	0.000997	0.00128	CbGpPWpGaD
Vitamin E—PRKCB—GPCR downstream signaling—DRD4—conduct disorder	0.000985	0.00127	CbGpPWpGaD
Vitamin E—PRKCA—Wnt Signaling Pathway and Pluripotency—EP300—conduct disorder	0.000984	0.00127	CbGpPWpGaD
Vitamin E—PPP2CB—RNF mutants show enhanced WNT signaling and proliferation—EP300—conduct disorder	0.000983	0.00127	CbGpPWpGaD
Vitamin E—NQO1—Metabolism—CGA—conduct disorder	0.000971	0.00125	CbGpPWpGaD
Vitamin E—PRKCA—Immune System—MB21D1—conduct disorder	0.000961	0.00124	CbGpPWpGaD
Vitamin E—PPP2CA—TCF dependent signaling in response to WNT—EP300—conduct disorder	0.000951	0.00122	CbGpPWpGaD
Vitamin E—GSTM3—Metabolism—COMT—conduct disorder	0.000947	0.00122	CbGpPWpGaD
Vitamin E—PRKCB—Signaling Pathways—CGA—conduct disorder	0.000944	0.00121	CbGpPWpGaD
Vitamin E—ALOX5—Metabolism—CGA—conduct disorder	0.000941	0.00121	CbGpPWpGaD
Vitamin E—GSTM3—Metabolism—MAOA—conduct disorder	0.000941	0.00121	CbGpPWpGaD
Vitamin E—PPP2CA—RNF mutants show enhanced WNT signaling and proliferation—EP300—conduct disorder	0.00092	0.00118	CbGpPWpGaD
Vitamin E—SOD1—Cellular responses to stress—EP300—conduct disorder	0.000918	0.00118	CbGpPWpGaD
Vitamin E—PPP2CB—Signaling by WNT in cancer—EP300—conduct disorder	0.000913	0.00117	CbGpPWpGaD
Vitamin E—PPP2CB—Signaling Pathways—CGA—conduct disorder	0.000906	0.00117	CbGpPWpGaD
Vitamin E—PRKCB—Signaling by GPCR—DRD4—conduct disorder	0.000895	0.00115	CbGpPWpGaD
Vitamin E—PRKCA—GPCR downstream signaling—CGA—conduct disorder	0.000892	0.00115	CbGpPWpGaD
Vitamin E—PPP2CB—Signaling by GPCR—DRD4—conduct disorder	0.000859	0.00111	CbGpPWpGaD
Vitamin E—GSTO1—Metabolism—COMT—conduct disorder	0.000857	0.0011	CbGpPWpGaD
Vitamin E—PPP2CA—Signaling by WNT in cancer—EP300—conduct disorder	0.000855	0.0011	CbGpPWpGaD
Vitamin E—GSTO1—Metabolism—MAOA—conduct disorder	0.000851	0.0011	CbGpPWpGaD
Vitamin E—PPP2CA—Signaling Pathways—CGA—conduct disorder	0.000849	0.00109	CbGpPWpGaD
Vitamin E—PRKCA—Signaling by GPCR—CGA—conduct disorder	0.00081	0.00104	CbGpPWpGaD
Vitamin E—PPP2CA—Signaling by GPCR—DRD4—conduct disorder	0.000805	0.00104	CbGpPWpGaD
Vitamin E—GSTP1—Cellular responses to stress—EP300—conduct disorder	0.000801	0.00103	CbGpPWpGaD
Vitamin E—PRKCB—Signaling by Wnt—EP300—conduct disorder	0.000783	0.00101	CbGpPWpGaD
Vitamin E—DGKA—Signaling Pathways—HTR2A—conduct disorder	0.000765	0.000985	CbGpPWpGaD
Vitamin E—PRKCB—Signaling Pathways—WASF1—conduct disorder	0.000756	0.000974	CbGpPWpGaD
Vitamin E—PPP2CB—Signaling by Wnt—EP300—conduct disorder	0.000752	0.000969	CbGpPWpGaD
Vitamin E—PPP2CB—Signaling Pathways—WASF1—conduct disorder	0.000726	0.000935	CbGpPWpGaD
Vitamin E—GCLC—Metabolism—COMT—conduct disorder	0.000718	0.000924	CbGpPWpGaD
Vitamin E—GCLC—Metabolism—MAOA—conduct disorder	0.000713	0.000918	CbGpPWpGaD
Vitamin E—PRKCA—Immune System—POLR3A—conduct disorder	0.000705	0.000908	CbGpPWpGaD
Vitamin E—PPP2CA—Signaling by Wnt—EP300—conduct disorder	0.000705	0.000907	CbGpPWpGaD
Vitamin E—PRKCA—Gene Expression—POLR3A—conduct disorder	0.000701	0.000903	CbGpPWpGaD
Vitamin E—PPP2CA—Signaling Pathways—WASF1—conduct disorder	0.00068	0.000876	CbGpPWpGaD
Vitamin E—PRKCB—GPCR downstream signaling—HTR2A—conduct disorder	0.000643	0.000827	CbGpPWpGaD
Vitamin E—PRKCA—Integrated Pancreatic Cancer Pathway—EP300—conduct disorder	0.000596	0.000767	CbGpPWpGaD
Vitamin E—PRKCA—Immune System—WASF1—conduct disorder	0.000593	0.000764	CbGpPWpGaD
Vitamin E—PRKCB—Signaling by GPCR—HTR2A—conduct disorder	0.000584	0.000751	CbGpPWpGaD
Vitamin E—PRKCA—Metabolism—CGA—conduct disorder	0.000573	0.000737	CbGpPWpGaD
Vitamin E—PRKCB—Cell Cycle, Mitotic—EP300—conduct disorder	0.000569	0.000732	CbGpPWpGaD
Vitamin E—PPP2CB—Signaling by GPCR—HTR2A—conduct disorder	0.000561	0.000722	CbGpPWpGaD
Vitamin E—PPP2CB—Cell Cycle, Mitotic—EP300—conduct disorder	0.000546	0.000703	CbGpPWpGaD
Vitamin E—SOD1—Hemostasis—EP300—conduct disorder	0.000545	0.000702	CbGpPWpGaD
Vitamin E—GSTA2—Metabolism—COMT—conduct disorder	0.000544	0.0007	CbGpPWpGaD
Vitamin E—GSTA2—Metabolism—MAOA—conduct disorder	0.00054	0.000695	CbGpPWpGaD
Vitamin E—PRKCB—Hemostasis—EP300—conduct disorder	0.000539	0.000694	CbGpPWpGaD
Vitamin E—PRKCB—Signaling Pathways—DRD4—conduct disorder	0.000528	0.00068	CbGpPWpGaD
Vitamin E—PPP2CA—Signaling by GPCR—HTR2A—conduct disorder	0.000525	0.000676	CbGpPWpGaD
Vitamin E—PPP2CB—Hemostasis—EP300—conduct disorder	0.000518	0.000666	CbGpPWpGaD
Vitamin E—PPP2CA—Cell Cycle, Mitotic—EP300—conduct disorder	0.000512	0.000659	CbGpPWpGaD
Vitamin E—PRKCB—Cell Cycle—EP300—conduct disorder	0.000508	0.000655	CbGpPWpGaD
Vitamin E—PPP2CB—Signaling Pathways—DRD4—conduct disorder	0.000508	0.000653	CbGpPWpGaD
Vitamin E—PRKCA—GPCR downstream signaling—DRD4—conduct disorder	0.0005	0.000643	CbGpPWpGaD
Vitamin E—PPP2CB—Metabolism—COMT—conduct disorder	0.000489	0.00063	CbGpPWpGaD
Vitamin E—PPP2CB—Cell Cycle—EP300—conduct disorder	0.000488	0.000629	CbGpPWpGaD
Vitamin E—PPP2CB—Metabolism—MAOA—conduct disorder	0.000486	0.000625	CbGpPWpGaD
Vitamin E—PPP2CA—Hemostasis—EP300—conduct disorder	0.000485	0.000624	CbGpPWpGaD
Vitamin E—PRKCA—Signaling Pathways—CGA—conduct disorder	0.000479	0.000616	CbGpPWpGaD
Vitamin E—PPP2CA—Signaling Pathways—DRD4—conduct disorder	0.000475	0.000612	CbGpPWpGaD
Vitamin E—PPP2CB—Innate Immune System—EP300—conduct disorder	0.000466	0.0006	CbGpPWpGaD
Vitamin E—PPP2CA—Metabolism—COMT—conduct disorder	0.000458	0.00059	CbGpPWpGaD
Vitamin E—PPP2CA—Cell Cycle—EP300—conduct disorder	0.000457	0.000589	CbGpPWpGaD
Vitamin E—PPP2CA—Metabolism—MAOA—conduct disorder	0.000455	0.000586	CbGpPWpGaD
Vitamin E—PRKCA—Signaling by GPCR—DRD4—conduct disorder	0.000454	0.000584	CbGpPWpGaD
Vitamin E—GSTP1—Metabolism—COMT—conduct disorder	0.00045	0.000579	CbGpPWpGaD
Vitamin E—HMOX1—Metabolism—EP300—conduct disorder	0.000447	0.000576	CbGpPWpGaD
Vitamin E—GSTP1—Metabolism—MAOA—conduct disorder	0.000447	0.000575	CbGpPWpGaD
Vitamin E—GSTO1—Disease—EP300—conduct disorder	0.000439	0.000565	CbGpPWpGaD
Vitamin E—NQO1—Metabolism—COMT—conduct disorder	0.000439	0.000565	CbGpPWpGaD
Vitamin E—PPP2CA—Innate Immune System—EP300—conduct disorder	0.000436	0.000562	CbGpPWpGaD
Vitamin E—NQO1—Metabolism—MAOA—conduct disorder	0.000435	0.000561	CbGpPWpGaD
Vitamin E—ALOX5—Metabolism—COMT—conduct disorder	0.000425	0.000547	CbGpPWpGaD
Vitamin E—ALOX5—Metabolism—MAOA—conduct disorder	0.000422	0.000543	CbGpPWpGaD
Vitamin E—ALOX5—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.000409	0.000526	CbGpPWpGaD
Vitamin E—GSTM3—Metabolism—EP300—conduct disorder	0.000406	0.000523	CbGpPWpGaD
Vitamin E—DGKA—Signaling Pathways—EP300—conduct disorder	0.000405	0.000522	CbGpPWpGaD
Vitamin E—PRKCA—Signaling by Wnt—EP300—conduct disorder	0.000397	0.000512	CbGpPWpGaD
Vitamin E—PRKCA—Signaling Pathways—WASF1—conduct disorder	0.000384	0.000494	CbGpPWpGaD
Vitamin E—GSTO1—Metabolism—EP300—conduct disorder	0.000367	0.000473	CbGpPWpGaD
Vitamin E—PRKCB—Signaling Pathways—HTR2A—conduct disorder	0.000345	0.000444	CbGpPWpGaD
Vitamin E—PPP2CB—Signaling Pathways—HTR2A—conduct disorder	0.000331	0.000426	CbGpPWpGaD
Vitamin E—PRKCA—GPCR downstream signaling—HTR2A—conduct disorder	0.000326	0.00042	CbGpPWpGaD
Vitamin E—PPP2CA—Signaling Pathways—HTR2A—conduct disorder	0.00031	0.000399	CbGpPWpGaD
Vitamin E—GCLC—Metabolism—EP300—conduct disorder	0.000308	0.000396	CbGpPWpGaD
Vitamin E—PRKCA—Signaling by GPCR—HTR2A—conduct disorder	0.000296	0.000381	CbGpPWpGaD
Vitamin E—PRKCA—Cell Cycle, Mitotic—EP300—conduct disorder	0.000289	0.000371	CbGpPWpGaD
Vitamin E—PRKCB—Immune System—EP300—conduct disorder	0.000283	0.000364	CbGpPWpGaD
Vitamin E—PRKCA—Hemostasis—EP300—conduct disorder	0.000273	0.000352	CbGpPWpGaD
Vitamin E—PPP2CB—Immune System—EP300—conduct disorder	0.000271	0.000349	CbGpPWpGaD
Vitamin E—PRKCA—Signaling Pathways—DRD4—conduct disorder	0.000268	0.000345	CbGpPWpGaD
Vitamin E—PRKCA—Metabolism—COMT—conduct disorder	0.000258	0.000333	CbGpPWpGaD
Vitamin E—PRKCA—Cell Cycle—EP300—conduct disorder	0.000258	0.000332	CbGpPWpGaD
Vitamin E—PRKCA—Metabolism—MAOA—conduct disorder	0.000257	0.00033	CbGpPWpGaD
Vitamin E—PPP2CA—Immune System—EP300—conduct disorder	0.000254	0.000327	CbGpPWpGaD
Vitamin E—PPP2CB—Disease—EP300—conduct disorder	0.000251	0.000323	CbGpPWpGaD
Vitamin E—PRKCA—Innate Immune System—EP300—conduct disorder	0.000246	0.000317	CbGpPWpGaD
Vitamin E—PPP2CA—Disease—EP300—conduct disorder	0.000235	0.000302	CbGpPWpGaD
Vitamin E—GSTA2—Metabolism—EP300—conduct disorder	0.000233	0.0003	CbGpPWpGaD
Vitamin E—PPP2CB—Metabolism—EP300—conduct disorder	0.00021	0.00027	CbGpPWpGaD
Vitamin E—PPP2CA—Metabolism—EP300—conduct disorder	0.000197	0.000253	CbGpPWpGaD
Vitamin E—GSTP1—Metabolism—EP300—conduct disorder	0.000193	0.000248	CbGpPWpGaD
Vitamin E—NQO1—Metabolism—EP300—conduct disorder	0.000188	0.000242	CbGpPWpGaD
Vitamin E—PRKCB—Signaling Pathways—EP300—conduct disorder	0.000183	0.000235	CbGpPWpGaD
Vitamin E—ALOX5—Metabolism—EP300—conduct disorder	0.000182	0.000234	CbGpPWpGaD
Vitamin E—PPP2CB—Signaling Pathways—EP300—conduct disorder	0.000175	0.000226	CbGpPWpGaD
Vitamin E—PRKCA—Signaling Pathways—HTR2A—conduct disorder	0.000175	0.000225	CbGpPWpGaD
Vitamin E—PPP2CA—Signaling Pathways—EP300—conduct disorder	0.000164	0.000212	CbGpPWpGaD
Vitamin E—PRKCA—Immune System—EP300—conduct disorder	0.000143	0.000185	CbGpPWpGaD
Vitamin E—PRKCA—Disease—EP300—conduct disorder	0.000132	0.00017	CbGpPWpGaD
Vitamin E—PRKCA—Metabolism—EP300—conduct disorder	0.000111	0.000143	CbGpPWpGaD
Vitamin E—PRKCA—Signaling Pathways—EP300—conduct disorder	9.27e-05	0.000119	CbGpPWpGaD
